2Iu PH, Negin RS. A novel population of expanded human CD3 "CD56" ceils derived from T cells with potent in vivo antitumor activity in mice with ervere combined immunodeficiency [ J ]. J lrnmunol, 1994,153 (4) : ! 687 - 1696.
3Hold L, Rieser C,Papesh C, et al. Cellular and humoral immune re-spou- ses in patients with metastatic renal cell carcinoma after vaccinationwith a.ntigensed dendritic cells[ J]. Urol, 1999,161 ( 3 ) :777 - 782.
5Schmidt-Wolf 1G, Lefterova P, Johnston V, et al. Propagation of large numbers of T cells with natural killer cell markers [ J ]. Br JHaemato, 1994,87(3) :453 -458.
6Schmidt-Wolf IG, Negrin I2S, ICian I-IP, et al. Use of a 9 CID mouse/hu- man lymphoma model to evaluate cytokine-induced killer cells with po- tent antitumor cell aetivity[ J]. J Exp Med, 1991 , 174( 1 ) : 139 - 149.
7Scheffold C, Brandtk,Johnston V, et al. Potential of autologous immuno- logic effector cells forbonemarrow purging in pa-tientswith chronic mye- loid leukemia[J]. Bone Marrow Trans-plant, 1995,15 ( 1 ) :33 - 39.
8Hongeng S, Petvises S, Worapongpaiboon S, et al. Generation of CD3+ CDs+ cytokine-induced killer cells and their in vitro cytotoxicity againstpediatric cancer ceils [ J ]. Int JHema-to, 2003,77 ( 2 ) : 175 - 179.
9Introna m, Franceschettim, Ciocca A,et al. Rapid and massive expansion of cord blood-derived cytokine-indueed killer cells : an innovative propos- al for the treatment of leukemia relapse after cord blood transplantation [ J ]. Bone Marrow Transplant 2006,38 ( 9 ) :621 - 627.
10Linn YC, Hulk M. Cytokine-indueed killer cells: NK-like T cellswith cytotolytic specificity against leukemia[ J ]. Leuk Lym-phoma,2003,44 (9) :1457 - 1462.
6[1]Peck K, Sher YP, Shih JY, et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients[J]. Cancer Res, 1998, 58(13) :2761
7[2]Funaki NO, Tanaka J, Ohshio G, et al. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients[J]. Br J Cancer. 1998, 77(8) :1327
8[3]Banchereau J, Steinman R. Dendritic cells and the control of immunity[J]. Nature, 1998, 392:245
9[4]Avigan D. Dendritic cells: development, function and potential use for cancer immunotherapy[J]. Blood Rev, 1999,13(1):51
10[5]Schmidt-Wolf I, Negrin R, Kiem H, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J3. J Exp Med,1991, 174:139
2Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：83
6Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cells carcinoma after vaccination with tumor cell dendritic cell hybrids[J]. Nat Med, 2000, 6(3) : 332 - 336.
7Marten A, Flieger D, Renoth S, et al. Therapeutic vaccination against metastaic renal cell carcinoma by autologous dendritic cells [J]. Cancer Immunol Immunother, 2002, 51 (11 - 12) : 637 - 644.
8Angena M, Sabing R , Marie LT, et al. Enhanced lyric activityof cytokine induced killer cells against multiple myeloma cells after co - culture with idiotype - pulsed dendritic cells[J]. Haematologica, 2011,86(10):1 029- 1 037.
9Fujii S, Shimizu K, Kronenberg M, et al, Prolonged IFN - gaml maproducing NKT response induced with alphagalactosylceramide - loaded DCs[J] Nat Immunol, 2002, 3(9): 867 - 874.
